Print

NovaBay Pharmaceuticals, Inc. (NBY) Releases Video of Recent Analyst and Investor Event in New York  
9/27/2013 10:35:36 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

EMERYVILLE, Calif.--(BUSINESS WIRE)--NovaBay Pharmaceuticals, Inc., an advanced clinical-stage biopharmaceutical company developing topical antimicrobial products, today released a video of its Analyst and Investor Event which was held on September 17th in New York City. At the event, Dr. Ron Najafi, Chairman and Chief Executive Officer of NovaBay, provided an overview of the company’s goals and milestones reached. NovaBay senior management team along with the clinicians involved in the study and key opinion leaders presented the data from NovaBay’s phase 2 clinical study of auriclosene to reduce urinary catheter blockage and encrustation (UCBE) of indwelling urinary catheters.

Help employers find you! Check out all the jobs and post your resume.

//-->